Clinical experience with isavuconazole in healthy volunteers and patients with invasive aspergillosis in China, and the results from an exposure-response analysis.
Jing ZhangYingyuan ZhangDepei WuGuoying CaoKamal A HamedAmit DesaiJalal A AramXuan GuoRana FayyadOliver Andreas CornelyPublished in: Mycoses (2021)
Although further research is required, this study demonstrated a favourable risk-benefit profile of isavuconazole in Chinese patients.
Keyphrases